BNTX logo

BioNTech SE (BNTX) Cash from investing

annual CFI:

-$2.25B+$5.27B(+70.06%)
December 31, 2024

Summary

  • As of today (August 18, 2025), BNTX annual cash flow from investing activities is -$2.25 billion, with the most recent change of +$5.27 billion (+70.06%) on December 31, 2024.
  • During the last 3 years, BNTX annual CFI has fallen by -$1.58 billion (-236.44%).
  • BNTX annual CFI is now -5968.06% below its all-time high of -$37.10 million, reached on December 31, 2022.

Performance

BNTX Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXcash flow metrics

quarterly CFI:

-$26.67M-$1.34B(-102.03%)
June 30, 2025

Summary

  • As of today (August 18, 2025), BNTX quarterly cash flow from investing activities is -$26.67 million, with the most recent change of -$1.34 billion (-102.03%) on June 30, 2025.
  • Over the past year, BNTX quarterly CFI has increased by +$222.17 million (+89.28%).
  • BNTX quarterly CFI is now -102.03% below its all-time high of $1.31 billion, reached on March 31, 2025.

Performance

BNTX quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXcash flow metrics

TTM CFI:

$1.77B+$222.17M(+14.33%)
June 30, 2025

Summary

  • As of today (August 18, 2025), BNTX TTM cash flow from investing activities is $1.77 billion, with the most recent change of +$222.17 million (+14.33%) on June 30, 2025.
  • Over the past year, BNTX TTM CFI has increased by +$8.71 billion (+125.54%).
  • BNTX TTM CFI is now at all-time high.

Performance

BNTX TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

BNTX Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+70.1%+89.3%+125.5%
3 y3 years-236.4%+71.5%+577.8%
5 y5 years-2508.3%-151.3%+2954.7%

BNTX Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-5968.1%+70.1%-102.0%+99.1%at high+119.3%
5 y5-year-5968.1%+70.1%-102.0%+99.1%at high+119.3%
alltimeall time-5968.1%+70.1%-102.0%+99.1%at high+119.3%

BNTX Cash from investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$26.67M(-102.0%)
$1.77B(+14.3%)
Mar 2025
-
$1.31B(+102.1%)
$1.55B(-168.5%)
Dec 2024
-$2.25B(-70.1%)
$649.24M(-499.2%)
-$2.26B(-60.6%)
Sep 2024
-
-$162.62M(-34.6%)
-$5.75B(-17.2%)
Jun 2024
-
-$248.84M(-90.1%)
-$6.94B(-24.4%)
Mar 2024
-
-$2.50B(-11.8%)
-$9.18B(+22.9%)
Dec 2023
-$7.52B(>+9900.0%)
-$2.84B(+109.5%)
-$7.47B(+55.5%)
Sep 2023
-
-$1.35B(-45.7%)
-$4.80B(+35.5%)
Jun 2023
-
-$2.49B(+215.8%)
-$3.55B(+208.8%)
Mar 2023
-
-$789.04M(+362.4%)
-$1.15B(+3018.8%)
Dec 2022
-$37.10M(-94.5%)
-$170.65M(+79.4%)
-$36.82M(-91.2%)
Sep 2022
-
-$95.09M(+1.7%)
-$417.24M(+12.5%)
Jun 2022
-
-$93.49M(-129.0%)
-$370.94M(+18.4%)
Mar 2022
-
$322.41M(-158.5%)
-$313.33M(-53.2%)
DateAnnualQuarterlyTTM
Dec 2021
-$669.12M(+305.2%)
-$551.06M(+1029.3%)
-$669.83M(+185.9%)
Sep 2021
-
-$48.80M(+36.0%)
-$234.31M(+12.2%)
Jun 2021
-
-$35.88M(+5.3%)
-$208.74M(+13.8%)
Mar 2021
-
-$34.09M(-70.5%)
-$183.48M(+10.6%)
Dec 2020
-$165.12M(+91.3%)
-$115.54M(+397.3%)
-$165.84M(+166.7%)
Sep 2020
-
-$23.24M(+118.9%)
-$62.18M(+0.2%)
Jun 2020
-
-$10.61M(-35.5%)
-$62.08M(-4.8%)
Mar 2020
-
-$16.45M(+38.5%)
-$65.20M(-24.6%)
Dec 2019
-$86.31M(+9.0%)
-$11.88M(-48.7%)
-$86.43M(+15.9%)
Sep 2019
-
-$23.14M(+68.4%)
-$74.55M(+45.0%)
Jun 2019
-
-$13.74M(-63.5%)
-$51.41M(+36.5%)
Mar 2019
-
-$37.68M
-$37.68M
Dec 2018
-$79.22M(+33.7%)
-
-
Dec 2017
-$59.27M
-
-

FAQ

  • What is BioNTech SE annual cash flow from investing activities?
  • What is the all time high annual CFI for BioNTech SE?
  • What is BioNTech SE annual CFI year-on-year change?
  • What is BioNTech SE quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for BioNTech SE?
  • What is BioNTech SE quarterly CFI year-on-year change?
  • What is BioNTech SE TTM cash flow from investing activities?
  • What is the all time high TTM CFI for BioNTech SE?
  • What is BioNTech SE TTM CFI year-on-year change?

What is BioNTech SE annual cash flow from investing activities?

The current annual CFI of BNTX is -$2.25B

What is the all time high annual CFI for BioNTech SE?

BioNTech SE all-time high annual cash flow from investing activities is -$37.10M

What is BioNTech SE annual CFI year-on-year change?

Over the past year, BNTX annual cash flow from investing activities has changed by +$5.27B (+70.06%)

What is BioNTech SE quarterly cash flow from investing activities?

The current quarterly CFI of BNTX is -$26.67M

What is the all time high quarterly CFI for BioNTech SE?

BioNTech SE all-time high quarterly cash flow from investing activities is $1.31B

What is BioNTech SE quarterly CFI year-on-year change?

Over the past year, BNTX quarterly cash flow from investing activities has changed by +$222.17M (+89.28%)

What is BioNTech SE TTM cash flow from investing activities?

The current TTM CFI of BNTX is $1.77B

What is the all time high TTM CFI for BioNTech SE?

BioNTech SE all-time high TTM cash flow from investing activities is $1.77B

What is BioNTech SE TTM CFI year-on-year change?

Over the past year, BNTX TTM cash flow from investing activities has changed by +$8.71B (+125.54%)
On this page